AA - Pharmaceutical giant Pfizer launched its research and development (R&D) office in the Turkish capital on Tuesday. The office is the result of a strategic cooperation initiated last year between drug maker Pfizer and Türkiye's Hacettepe University and it is aiming to support studies on molecular discovery, said a senior official in Pfizer during the opening ceremony in Ankara.
Tom Azoulay said Türkiye is a very important country for global drug giant, adding that Pfizer believes in Turkish universities and scientists. Azoulay also said the project will be a scientific bridge between Türkiye and Pfizer.
Pfizer and Hacettepe University plan to carry out projects on new drug discoveries, information transfer, infrastructure development and support of scientific researches. Turkish scientist and their innovative ideas will be included in Pfizer's global R&D studies.